Login / Signup

Comparison of the on-treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis.

Ingyoon HaJung Wha ChungEun Sun JangSook-Hyang JeongJin-Wook Kim
Published in: Journal of gastroenterology and hepatology (2020)
ETV and TDF treatment was associated with similar risk for HCC development in CHB patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • acute lymphoblastic leukemia
  • prognostic factors
  • peritoneal dialysis
  • risk assessment
  • human health
  • antiretroviral therapy
  • patient reported